Document is current
Any future updates will be listed below
-
Authors
Faravelli, Irene
Antón-Bolaños, Noelia https://orcid.org/0000-0001-6590-4316
Wei, Anqi
Faits, Tyler https://orcid.org/0000-0002-7524-6166
Kumar, Abhishek Sampath https://orcid.org/0000-0001-7918-6706
Andreadis, Sophia
Kastli, Rahel https://orcid.org/0000-0002-3810-6228
Crespo, Marta Montero https://orcid.org/0000-0002-7895-5961
Steiger, Mara https://orcid.org/0000-0002-3747-685X
Leible, Daniel https://orcid.org/0009-0006-5491-6673
Zhang, Elizabeth https://orcid.org/0009-0006-8032-9421
An, Bobae
Meirovitch, Yaron
Silwal, Sayara
Yang, Sung Min
Kovacsovics, Alexander
Adiconis, Xian
Kretzmer, Helene https://orcid.org/0000-0002-0723-4980
Levin, Joshua Z. https://orcid.org/0000-0002-0170-3598
Boyden, Edward S. https://orcid.org/0000-0002-0419-3351
Lichtman, Jeff https://orcid.org/0000-0002-0208-3212
Regev, Aviv
Meissner, Alexander https://orcid.org/0000-0001-8646-7469
Arlotta, Paola https://orcid.org/0000-0003-2184-2277
- License Information
-
More Information
Article History
Received: 2 July 2025
Accepted: 1 July 2026
First Online: 19 August 2026
Change Date: 25 August 2026
Change Type: Update
Change Details: In the version of this article initially published, the corresponding author email for Paola Arlotta was displayed incorrectly and is now amended in the HTML and PDF versions of the article.
Ethics
Competing interests: P.A. is a scientific advisory board member at Foresite Labs, and is a co-founder of Vesalius and a co-founder and equity holder at Foresite Labs and at Avatar Bio. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until 31 August 2020, was a scientific advisory board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and Thermo Fisher Scientific. From 1 August 2020, A.R. has been an employee of Genentech and has equity in Roche. A.M. is a co-founder and scientific advisor of Harbinger Health, and is on the scientific advisory board of Zymo Research.
